A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine

Vaccine

Volumn 28, Issue 36, 2010, Pages 5900-5902

  Puthanakit, Thanyawee ^a   Aurpibul, Linda ^a   Yoksan, Sutee ^b   Sirisanthana, Thira ^a   Sirisanthana Virat, V ^c  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Human immunodeficiency virus (HIV); Japanese encephalitis virus; Protective antibody

Indexed keywords

CD4 ANTIGEN; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPANESE ENCEPHALITIS VIRUS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVACCINATION; SCHOOL CHILD;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; ENCEPHALITIS, JAPANESE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; JAPANESE ENCEPHALITIS VACCINES; MALE; NEUTRALIZATION TESTS;

EID: 77955554974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.048     Document Type: Article

References (15)

1. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 2000, 18(May (Suppl. 2)):1-25.
2. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. The New England Journal of Medicine 1988, 319(September (10)):608-614.
3. Nimmannitya S., Hutamai S., Kalayanarooj S., Rojanasuphot S. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines. The Southeast Asian Journal of Tropical Medicine and Public Health 1995, 26(December (4)):689-693.
4. Hennessy S., Liu Z., Tsai T.F., Strom B.L., Wan C.M., Liu H.L., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 1996, 347(June (9015)):1583-1586.
5. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001, 358(September (9284)):791-795.
6. Obaro S.K., Pugatch D., Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The Lancet Infectious Diseases 2004, 4(August (8)):510-518.
7. Rojanasuphot S., Shaffer N., Chotpitayasunondh T., Phumiamorn S., Mock P., Chearskul S., et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health 1998, 29(September (3)):443-450.
8. Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clinical Infectious Diseases 2007, 45(September (5)):637-642.
9. Lao-araya M., Puthanakit T., Aurpibul L., Sirisanthana T., Sirisanthana V. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine 2007, 25(July (29)):5324-5329.
10. Puthanakit T., Aurpibul L., Yoksan S., Sirisanthana T., Sirisanthana V. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 2007, 25(November (49)):8257-8261.
11. Russell P.K., Nisalak A., Sukhavachana P., Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. Journal of Immunology 1967, 99:285-290.
12. Abe M., Okada K., Hayashida K., Matsuo F., Shiosaki K., Miyazaki C., et al. Duration of neutralizing antibody titer after Japanese encephalitis vaccination. Microbiology and Immunology 2007, 51(6):609-616.
13. Tseng H.F., Tan H.F., Chang C.K., Huang W.L., Ho W.C. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships. American Journal of Infection Control 2003, 31(November (7)):435-440.
14. Marfin A.A., Gubler D.J. Japanese encephalitis: the need for a more effective vaccine. Lancet 2005, 366(October (9494)):1335-1337.
15. Veit O., Niedrig M., Chapuis-Taillard C., Cavassini M., Mossdorf E., Schmid P., et al. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clinical Infectious Diseases 2009, 48(March (5)):659-666.